EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients

Nuobing Yang, Hui Wang, Xiaomeng Feng, Qingsong Lin, Biyun Chen iD, Yingchang Mi, Yizhou Zheng, Lugui Qiu, Fengkui Zhang, Erlie Jiang, Mingzhe Han, Zhijian Xiao und 2 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02325-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Nuobing Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Natural Sciences Foundation of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To explore the clinical characteristics and outcomes of Staphylococcus aureus bacteremia (SAB) in patients with hematological diseases and evaluate the efficacy of short-course antibiotic therapy for uncomplicated SAB in this group. We performed a retrospective study on hematological adult patients with SAB, including a high proportion of neutropenic patients. Logistic regression models fitted with inverse probability of treatment weighting were employed to evaluate the association between treatment duration and clinical outcomes in patients with uncomplicated SAB. A total of 242 patients infected with SAB were included, of whom 38 (15.7%) were caused by MRSA. The 90-day mortality and 30-day mortality rate were 11.2% ( n = 27) and 4.5% ( n = 11), respectively, while the 90-day recurrence rate was 5.4% ( n = 13). Multivariate analysis indicated that advanced age (odds ratio [OR] = 1.063, P = 0.004), relapsed or refractory hematological diseases (OR = 14.439, P < 0.001), and polymicrobial infection (OR = 5.102, P = 0.020) were independent predictors of 90-day mortality, while MRSA bacteremia was an independent predictor of 30-day mortality (OR = 14.091, P = 0.009). Among 191 patients with uncomplicated SAB, 89 patients received short-course (median, 8.0 days; IQR, 7.0-9.0) and 102 received long-course therapy (median, 15.0 days; IQR, 12.0-19.3). In the weighted cohort, the multivariate analysis indicated that a short course of antibiotic treatment showed no significant relation with 90-day mortality (OR = 0.595, P = 0.486), 30-day mortality (OR = 0.784, P = 0.832) or 90-day recurrence (OR = 1.80, P = 0.373). For hematological adult patients infected with SAB, MRSA, and polymicrobial infection associated with poor outcomes. Short-course antibiotic therapy for uncomplicated SAB seemed to yield similar clinical outcomes as long-course one. IMPORTANCE There is still no consensus on the optimal antibiotic course for Staphylococcus aureus bacteremia (SAB) in patients with hematological diseases. Some studies have suggested that short-course antibiotic therapy was feasible for uncomplicated SAB, but few have targeted hematological patients. Here, we described clinical characteristics and outcomes of SAB in hematological patients and highlighted advanced age, refractory or relapsed hematological diseases, and polymicrobial infection as independent predictors of 90-day mortality, while MRSA bacteremia was associated with early mortality risk. And we demonstrated that short-course antibiotic therapy (≤10 days) for uncomplicated SAB in hematological patients was non-inferior to long-course one (>10 days).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteremiaStaphylococcal InfectionsStaphylococcus aureusHematologic DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultTreatment OutcomeMethicillin-Resistant Staphylococcus aureusAged, 80 and over

Stichwörter der Autor:innen

Staphylococcus aureus bacteremiahematological diseasesneutropeniashort-course antibiotic therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.

ORCID-Profile: Biyun Chen, Sizhou Feng

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • National Natural Sciences Foundation of China
  • National Key R&D Program of China

Zitieren

APA

Yang, N., Wang, H., Feng, X., Lin, Q., Chen, B., Mi, Y., Zheng, Y., Qiu, L., Zhang, F., Jiang, E., Han, M., Xiao, Z., Wang, J., & Feng, S. (2025). Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02325-24

Vancouver

Yang N, Wang H, Feng X, Lin Q, Chen B, Mi Y, et al. Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02325-24

BibTeX
@article{Yang2025,
  author = {Yang, Nuobing and Wang, Hui and Feng, Xiaomeng and Lin, Qingsong and Chen, Biyun and Mi, Yingchang and Zheng, Yizhou and Qiu, Lugui and Zhang, Fengkui and Jiang, Erlie and Han, Mingzhe and Xiao, Zhijian and Wang, Jianxiang and Feng, Sizhou},
  title = {Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02325-24}
}
Kostenlos starten →